Defective HIV-1 provirus encoding a multitarget-ribozyme inhibits accumulation of spliced and unspliced HIV-1 mRNAs, reduces infectivity of viral progeny, and protects the cells from pathogenesis

Human Gene Therapy

Volumn 8, Issue 9, 1997, Pages 1115-1124

  Paik, Soon Young ^a,b   Banerjea, Akhil ^a   Chen, Chang Jie ^a   Ye, Zhiping ^a   Harmison, George G ^a   Schubert, Manfred ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHIMERIC PROTEIN; GLYCOPROTEIN GP 120; RIBOZYME; TRANSACTIVATOR PROTEIN; VIRUS DNA; VIRUS ENVELOPE PROTEIN; VIRUS MESSENGER RNA;

ARTICLE; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; NONHUMAN; PROVIRUS; RNA SPLICING; TRANSACTIVATION; VIRUS INFECTIVITY; VIRUS PATHOGENESIS; VIRUS REPLICATION;

DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; RNA VIRUSES;

EID: 0030838518     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.9-1115     Document Type: Article

References (43)

1. ADACHI, A., GLENDELMAN, H.E., KOENIG, S., FOLKS, T., WILLEY, R., RABSOM, A., and MARTIN, M. (1986). Production of acquired immunodeficiency syndrome associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59, 284-291.
2. BECK J., and NASSAL, M. (1995). Efficient hammerhead ribozyme-mediated cleavage of the structured hepatitis B virus encapsidation signal in vitro and in cell extracts, but not in intact cells. Nucleic Acids Res. 23, 4954-4962.
3. BERTHOLD, E., and MALDARELLI, F. (1996). Cis-acting elements in human immunodeficiency virus type 1 RNAs direct viral transcripts to distinct intranuclear locations. J. Virol. 70, 4667-4682.
4. BERTRAND, E.L., and ROSSI, J.J. (1994). Facilitation of hammerhead ribozyme catalysis by the nucleocapsid protein of HIV-1 and the heterogeneous nuclear ribonucleoprotein A1. EMBO J. 13, 2904-2912.
5. BLOCHLINGER, K., and DIGGELMANN, H. (1984). Hygromycin B phosphotransferase as a selectable marker for DNA transfer experiments with higher eucaryotic cells. Mol. Cell. Biol. 4, 2929-2931.
6. BUONOCORE, L., and ROSE, J.K. (1990). Prevention of HIV-1 glycoprotein transport by soluble CD4 retained in the endoplasmic reticulum. Nature 345, 625-628.
7. CANTOR, G.H., McELWAIN, T.F., BIRKEBAK, T.A., and PALMER, G.H. (1993). Ribozymes cleaves rex/tax mRNA and inhibits bovine leukemia virus expression. Proc. Natl. Acad. Sci. USA 90, 10932-10936.
8. CHEN, C.-J., BANERJEA, A.C., HARMISON, G.G., HAGLUND, K., and SCHUBERT, M. (1992). Multitarget-ribozyme directed to cleave at up to nine highly conserved HIV-1 env RNA regions inhibits HIV-1 replication-potential effectiveness against most presently sequenced HIV-1 isolates. Nucleic Acids Res. 20, 4581-4589.
9. CHEN, M.-Y., MALDARELLI, F., KARCZEWSKI, M.K., WILLEY, R.L., and STREBEL, K. (1993). Human immunodeficiency virus type 1 vpu protein induces degradation of CD4 in vitro: The cytoplasmic domain of CD4 contributes to vpu sensitivity. J. Virol. 67, 3877-3884.
10. CHIRGWIN, J.M., PRZYBYLA, A.E., MACDONALD, R.J., and RUTTER, W.J. (1979). Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18, 5294-5297.
11. DEEN, K.C., McDOUGAL, J.S., INACKER, R., FOLENA-WASSERMAN, G., ARTHOS, J., ROSENBERG, J., MADDON, P.J., AXEL, R., and SWEET, R.W. (1988). A soluble form of CD4 (T4) protein inhibits AIDS virus infection. Nature 331, 82-84.
12. DOLTER, K.E., KING, S.R., and HOLLAND, T.C. (1993). Incorporation of CD4 into virions by a recombinant herpes simplex virus. J. Virol. 67, 189-195.
13. DROPULIC, B., LIN, N.H., MARTIN, M.A., and JEANG, K.-T. (1992). Functional characterization of a U5 ribozyme: Intracellular suppression of human immunodeficiency virus type 1 expression. J. Virol. 66, 1432-1441.
14. DROPULIC, B., ELKINS, D.A., ROSSI, J.J., and SARVER, N. (1993). Ribozymes: use as anti-HIV therapeutic molecules. Antisense Res. Dev. 3, 87-94.
15. ENSOLI, B., BUONAGURO, L., BARILLARI, G., FIORELLI, V., GENDELMAN, R., MORGAN, R.A., WINGFIELD, P., and GALLO, R.C. (1993). Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 67, 277-287.
16. FERBEYRE, G., BRATTY, J., CHEN, H., and CEDERGREN, R. (1995). A hammerhead ribozyme inhibits ADE1 gene expression in yeast. Gene 155, 45-50.
17. GHEYSEN, D., JACOBS, E., DE FORESTA, F., THIRIART, C., FRANCOTTE, M., THINES, D., and DE WILDE, M. (1989). Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells. Cell 59, 103-112.
18. HEIDENREICH, O., KANG, S.-H., BROWN, D.A., XU, X., SWIDERSKI, P., ROSSI, J.J., ECKSTEIN, F., and NERENBERG, M. (1995). Ribozyme-mediated RNA degradation in nuclei suspension. Nucleic Acids Res. 23, 2223-2228.
19. IMAIZUMI, K., KATOH, T., TSUDA, M., TAKAGI, T., and KIYAMA, H. (1995). GAP-43 mRNA suppression by the ribozyme in PC12 cells and inhibition of evoked dopamine release. Brain Res. Mol. Brain Res. 32, 338-341.
20. JABBAR, M.A., and NAYAK, D.P. (1990). Intracellular interaction of human immunodeficiency virus type 1 (ARV-2) envelope glycoprotein gp160 with CD4 blocks the movement and maturation of CD4 to the plasma membrane. J. Virol. 64, 6297-6304.
21. KANDOLF, H. (1994). The H1A histone variant is an in vivo repressor of oocyte-type 5S gene transcription in Xenopus laevis embryos. Proc. Natl. Acad. Sci. USA 91, 7257-7261.
22. KIMPTON, J., and EMERMAN, M. (1992). Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. J. Virol. 66, 2232-2239.
23. KWON, H.Y., BULTMAN, S.J., LOEFFLER, C., CHEN, W.J., FURDON, P.J., POWELL, J.G., USALA, A.L., WILKISON, W., HANSMAN, I., and WOYCHIK, R.P. (1994). Molecular structure and chromosomal mapping of the human homolog of the agouti gene. Proc. Natl. Acad. Sci. USA 91, 9760-9764.
24. LO, K.M.S., BIASOLO, M.A., DEHNI, G., PALUE, G., and HASELTINE, W.A. (1992). Inhibition of replication of HIV-1 by retroviral vectors expressing tat-antisense and anti-tat ribozyme RNA. Virology 190, 176-183.
25. MADDON, P.J., LITTMAN, D.R., GODFRY, M., MADDON, D.E., CHESS, L., and AXEL, R. (1985). The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: A new member of the immunoglobulin gene family. Cell 42, 93-104.
26. MADDON, P.J., DALGLEISH, A.G., McDOUGAL, J.S., CLAPHAM, P.R., WEISS, R.A., and AXEL, R. (1986). The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47, 333-348.
27. MAEDA, A., HAYASHI, M., MIZUTANI, T., ISHIDA, K., WATANABE, T., and NAMIOKA, S. (1995). Inhibition of viral multiplication in cells chronically infected with mouse hepatitis virus by antisense RNA against the polymerase gene. J. Vet. Med. Sci. 57, 563-565.
28. MALIM, H.M., HAUBER, J., SHU-YUN, L., MAIZEL, J.V., and CULLEN, B.R. (1989). The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature 338, 254-257.
29. MANIATIS, T., FRITSCH, E.F., and SAMBROOK, J. (1982). Molecular Cloning: A Laboratory Manual. (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY).
30. OHKAWA, J., YUYAMA, N., TAKEBE, Y., NISHIKAWA, S., and TAIRA, K. (1993). Importance of independence in ribozyme reactions: Kinetic behavior of trimmed and of simply connected multiple ribozymes with potential activity against human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 90, 11302-11306.
31. PAIK, S.-Y., BANERJEA, A.C, HARMISON, G.G., CHEN, C.-J., and SCHUBERT, M. (1995). Inducible and conditional inhibition of human immunodeficiency virus proviral expression by vesicular stomatitis virus matrix protein. J. Virol. 69, 3529-3537.
32. PORTMAN, D.S., and DREYFUSS, G. (1994). RNA annealing activities in HeLa nuclei. EMBO J. 13, 213-221.
33. SAKAI, H., KAWAMURA, M., SAKURAGI, S., SHIBATA, R., ISHIMOTO, A., ONO, N., UEDA, S., and ADACHI, A. (1993). Integration is essential for efficient gene expression of human immunodeficiency virus type 1. J. Virol. 67, 1169-1174.
34. SARVER, N., CANTIN, E.M., CHANG, P.S., ZAIA, J.A., LADNE, D.A., and ROSSI, J.J. (1990). Ribozymes as potential anti-HIV-1 therapeutic agents. Science 247, 1222-1225.
35. SCHUBERT, M. JOSHI, B., BLONDEL, D., and HARMISON, G.G. (1992). Insertion of the human immunodeficiency virus CD4 receptor into the envelope of vesicular stomatitis virus. J. Virol. 66, 1579-1589.
36. SCHULZ, T.F., WHITBY, D., HOAD, J.G., CORRAH, T., WHITTLE, H., and WEISS, R.A. (1990). Biological and molecular variability of human immunodeficiency virus type 2 isolates from the Gambia. J. Virol. 64, 5177-5182.
37. SMITH, A.J., CHO, M.I., HAMMARSKJOLD, M.L., and REKOSH, D. (1990). Human immunodeficiency virus type 1 Pr55gag and Pr160gag-pol expressed from a simian virus 40 late replacement vector are efficiently processed and assembled into viruslike particles. J. Virol. 64, 2743-2750.
38. SULLENGER, B.A., and CECH, T.R. (1993). Tethering ribozymes to a retroviral packaging signal for destruction of viral RNA. Science 262, 1566-1569.
39. + lymphocyte-derived cell lines conferred by using retroviral vectors expressing an HIV-1 RNA-specific ribozyme. J. Virol. 65, 5531-5534.
40. WILLEY, R.L., MALDARELLI, F., MARTIN, M.A., and STREBEL, K. (1992). Human immunodeficiency virus type 1 vpu protein regulates the formation of intracellular gp160-CD4 complexes. J. Virol. 66, 226-234.
41. YAMADA, O., YU, M., YEE, J.K., KRAUS, G., LOONEY, D., and WONG-STAAL, F. (1994). Intracellular immunization of human T cells with a hairpin ribozyme against human immuodeficiency virus type 1. Gene Ther. 1, 38-45.
42. YOUNG, J.A.T., BATES, P., WILLERT, K., and VARMUS, H.E. (1990). Efficient incorporation of human CD4 protein into avian leukosis virus particles. Science 250, 1421-1423.
43. ZHOU, C., BAHNER, I.C., LARSON, G.P., ZAIA, J.A., ROSSI, J.J., and KOHN, D.B. (1994). Inihbition of HIV-1 in human T-lymphocytes by retrovirally transduced anti-tat and rev hammerhead ribozymes. Gene 149, 33-39.